Literature DB >> 1847620

Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester.

G Archipoff1, A Beretz, J M Freyssinet, C Klein-Soyer, C Brisson, J P Cazenave.   

Abstract

Thrombomodulin and tissue-factor activities were measured on the surface of confluent human saphenous-vein endothelial cells (HSVEC) cultivated in 96-multiwell plates. Thrombomodulin activity was measured in the presence of purified human thrombin (2.2 nM) and protein C (65 nM). Tissue-factor activity was measured with purified human Factor VII (5 nM) and Factor X (400 nM). Generated activated protein C and Factor Xa released in the supernatant were assayed with chromogenic substrates. Resting cells exhibited significant thrombomodulin activity, but no detectable tissue-factor activity. After 4 h of preincubation with tumour necrosis factor (TNF, 22-2200 pM), interleukin-1 (IL-1, 5.7-570 nM) or phorbol myristate acetate (PMA, 1.61-161 nM) there was an increase in tissue-factor activity and a concomitant decrease in thrombomodulin activity. However, the extent of both responses varied according to the nature of the stimulus. Thrombin (0.44-44 nM) also induced an increase in tissue-factor activity, but had no effect on thrombomodulin activity. Kinetic studies showed that for all stimuli the increase in tissue factor was transient, reaching a maximum after 4-8 h of preincubation with the stimulating agent and returning to normal values after 24 h. IL-1 and TNF induced a time-dependent decrease in thrombomodulin, by respectively 47% and 67% of control values after 24 h. However, PMA induced only a transient down-regulation of thrombomodulin, full activity being recovered after 18 h. Hence this simultaneous assay system, using intact HSVEC and purified human coagulation factors, enabled us to observe that the regulation of thrombin generation could be diversely affected by various substances known to stimulate the endothelium. This suggests that the simultaneous and opposite modulation of these proteins does not represent an unified response of the endothelial cells to procoagulant stimuli. These results also confirm the absence of effect of thrombin on the expression of thrombomodulin on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847620      PMCID: PMC1149817          DOI: 10.1042/bj2730679

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

Review 1.  Structure and function of thrombomodulin: a natural anticoagulant.

Authors:  W A Dittman; P W Majerus
Journal:  Blood       Date:  1990-01-15       Impact factor: 22.113

2.  Observations on the cell biology of tissue factor in endothelial cells.

Authors:  K Andoh; K S Pettersen; C Filion-Myklebust; H Prydz
Journal:  Thromb Haemost       Date:  1990-04-12       Impact factor: 5.249

3.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  An endothelial cell-dependent pathway of coagulation.

Authors:  D Stern; P Nawroth; D Handley; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture.

Authors:  P P Nawroth; D M Stern; W Kisiel; R Bach
Journal:  Thromb Res       Date:  1985-12-01       Impact factor: 3.944

6.  The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester.

Authors:  D C Crossman; D P Carr; E G Tuddenham; J D Pearson; J H McVey
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

7.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Self-regulation of procoagulant events on the endothelial cell surface.

Authors:  D M Stern; I Bank; P P Nawroth; J Cassimeris; W Kisiel; J W Fenton; C Dinarello; L Chess; E A Jaffe
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

9.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  15 in total

1.  Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.

Authors:  Huang-Joe Wang; Te-Ling Lu; Haimei Huang; Huey-Chun Huang
Journal:  Tex Heart Inst J       Date:  2011

2.  The regulation of uterine tissue factor by estrogen.

Authors:  S M Quirk; B T Pentecost; N Mackman; D J Loskutoff; S Hartzell; K P Henrikson
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

3.  Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.

Authors:  G Archipoff; A Beretz; K Bartha; C Brisson; C de la Salle; C Froget-Léon; C Klein-Soyer; J P Cazenave
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

Authors:  T Iba; Y Yagi; A Kidokoro; M Fukunaga; T Fukunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Neuropilin-1 targeting photosensitization-induced early stages of thrombosis via tissue factor release.

Authors:  Denise Bechet; Loraine Tirand; Béatrice Faivre; François Plénat; Corinne Bonnet; Thierry Bastogne; Céline Frochot; François Guillemin; Muriel Barberi-Heyob
Journal:  Pharm Res       Date:  2010-01-20       Impact factor: 4.200

6.  RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment.

Authors:  Chiu-Hung Yeh; Liang-Yi Hung; Chin Hsu; Shu-Yun Le; Pin-Tse Lee; Wan-Lin Liao; Yi-Tseng Lin; Wen-Chang Chang; Joseph T Tseng
Journal:  Mol Biol Cell       Date:  2008-06-25       Impact factor: 4.138

7.  Involvement of heat shock factor 1 in statin-induced transcriptional upregulation of endothelial thrombomodulin.

Authors:  Qiang Fu; Junru Wang; Marjan Boerma; Maaike Berbée; Xiaohua Qiu; Louis M Fink; Martin Hauer-Jensen
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

8.  Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis.

Authors:  Junru Wang; Huaien Zheng; Xuemei Ou; Louis M Fink; Martin Hauer-Jensen
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 9.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

10.  Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.

Authors:  C Ravanat; G Archipoff; A Beretz; G Freund; J P Cazenave; J M Freyssinet
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.